RU98101627A - MAGAKYAN ETERNAL SYRUP - Google Patents

MAGAKYAN ETERNAL SYRUP

Info

Publication number
RU98101627A
RU98101627A RU98101627/13A RU98101627A RU98101627A RU 98101627 A RU98101627 A RU 98101627A RU 98101627/13 A RU98101627/13 A RU 98101627/13A RU 98101627 A RU98101627 A RU 98101627A RU 98101627 A RU98101627 A RU 98101627A
Authority
RU
Russia
Prior art keywords
syrup
magakyan
eternal
hormone
dekamevit
Prior art date
Application number
RU98101627/13A
Other languages
Russian (ru)
Other versions
RU2152744C2 (en
Inventor
В.С. Магакьян
Original Assignee
В.С. Магакьян
Filing date
Publication date
Application filed by В.С. Магакьян filed Critical В.С. Магакьян
Priority to RU98101627A priority Critical patent/RU2152744C2/en
Priority claimed from RU98101627A external-priority patent/RU2152744C2/en
Publication of RU98101627A publication Critical patent/RU98101627A/en
Application granted granted Critical
Publication of RU2152744C2 publication Critical patent/RU2152744C2/en

Links

Claims (1)

Сироп, состоящий из спирта этилового, гематогена жидкого, поливитамина "Декамевит", гормона роста - мелатонина, универсального гормона - дегидроэпиандростерона, мужского полового гормона - тестостерона, отличающийся подбором компонентов и мас.% соотношением:
Спирт этиловый 40% - 21 г ( 63,063%)
Гематоген жидкий - 12 г (36,036%)
Поливитамин "Декамевит" - 0,287 г (0,861%)
Мелатонин - 0,005 г (0,015%)
Дегидроэпиандростерон - 0,005 г (0,015%)
Тестостерон - 0,003 г (0,010%)
и дозами гормональных препаратов, что в несколько раз меньше общепринятых медицинских норм дозировки данных препаратов.
Syrup consisting of ethyl alcohol, liquid hematogen, Dekamevit multivitamin, growth hormone - melatonin, universal hormone - dehydroepiandrosterone, male sex hormone - testosterone, differing in the selection of components and wt.
Ethyl alcohol 40% - 21 g (63.063%)
Hematogen liquid - 12 g (36.036%)
Multivitamin Dekamevit - 0.287 g (0.861%)
Melatonin - 0.005 g (0.015%)
Dehydroepiandrosterone - 0.005 g (0.015%)
Testosterone - 0.003 g (0.010%)
and doses of hormonal drugs, which is several times less than the generally accepted medical standards for the dosage of these drugs.
RU98101627A 1998-01-27 1998-01-27 Syrup RU2152744C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU98101627A RU2152744C2 (en) 1998-01-27 1998-01-27 Syrup

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU98101627A RU2152744C2 (en) 1998-01-27 1998-01-27 Syrup

Publications (2)

Publication Number Publication Date
RU98101627A true RU98101627A (en) 1999-12-10
RU2152744C2 RU2152744C2 (en) 2000-07-20

Family

ID=20201717

Family Applications (1)

Application Number Title Priority Date Filing Date
RU98101627A RU2152744C2 (en) 1998-01-27 1998-01-27 Syrup

Country Status (1)

Country Link
RU (1) RU2152744C2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2275930C2 (en) * 2004-04-26 2006-05-10 ООО "РусГен" Composition for correction of human endocrine system age-related changes (variants) and method for production of pharmaceutical formulation based on the same

Similar Documents

Publication Publication Date Title
RU95102778A (en) Use of 2-phenyl-3-aroylbenzothiophenes for osseous tissue loss inhibition and serum cholesterol level decrease, pharmaceutical preparation containing 2-phenyl-3-aroylbenzothiophene
RU2010111103A (en) COCOA EXTRACT COMPOUNDS AND METHODS FOR PRODUCING AND USING THEM
ID24901A (en) METHOD OF TREATMENT OF HIGH COAGAGULATION OR DEFICIENCY OF PROTEIN C OBTAINED
BR0015188A (en) Pharmaceutical compositions
WO1997048391A3 (en) Methods and compositions comprising r-ibuprofen
EP1830191A3 (en) Pharmaceutical preparations containing thiazolidinediones for the treatment of endocrine autoimmune diseases
AU2001292119A1 (en) Absorption enhancers
PL323364A1 (en) Bicyclic aromatic compounds
WO2002088100A3 (en) Deuterated 3-piperidinopropiophenone and medicaments containing said compounds
IT1211711B (en) ANTISEPTIC COMPOSITION FOR THE DISINFECTION OF THE HANDS OF DENTISTS AND DOCTORS, CONTAINING ETHYL ALCOHOL AND MONOLAURIN
CA2038744A1 (en) Pharmaceutical composition containing slightly water-soluble drug
EP0657167A3 (en) Use of oenotheine B for the manufacture of a medicament for the treatment of disorders related to hyperandrogenism, pharmaceutical compositions containing oenotheine B and a process for its preparation from epilobium parviflorum.
EG19302A (en) Compound with gastric acid inhibitory effect and process for its preparation
CA2340734A1 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivative and its use in the treatment of vascular diseases
EP1393738A4 (en) Drugs for diabetes
HUP0001104A2 (en) Pharmaceutical compositions containing ibuprofen and domperidone for the treatment of migraine
RU98101627A (en) MAGAKYAN ETERNAL SYRUP
RU98101105A (en) NEW APPLICATION FOR MEDICAL PURPOSES
BR0303384A (en) Citalopram And Its Uses In The Treatment Of High Blood Pressure
RU2000113775A (en) PREPARATION AND TREATMENT OF ENDOMETRITIS
EP1232748A4 (en) Substituted nitrobenzene derivatives as medicines and other useful uses thereof
RU2001122151A (en) DRUG FOR TREATMENT OF ACUTE POST-NENAL ENDOMETRITIS IN COWS AND METHOD OF ITS APPLICATION
EP1595879A3 (en) Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
WO2003040119A8 (en) Angiogenesis inhibitors
MIZUMA The Role of Physiatrist in Community Medicine from Standing Point of University Hospital